Study of CG0070 Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Edward Uchio
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- CG Oncology, Inc.
- ID
- NCT04452591
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 110 study participants
- Last Updated